Cc1ccc(C)c(Cn2nnc3c(O)nc(C4CCCN(C(=O)c5cccs5)C4)nc32)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?